-+ 0.00%
-+ 0.00%
-+ 0.00%

Belite Bio Chief Medical Officer Hendrik Peter Scholl Reports Sale of $331,976.10 in Common Shares

PUBT·11/17/2026 00:13:50
Listen to the news
Belite Bio Chief Medical Officer Hendrik Peter Scholl Reports Sale of $331,976.10 in Common Shares
  • Belite Bio Chief Medical Officer Hendrik Peter Scholl sold 2,000 American depositary shares on Nov. 12, 2026.
  • Two 500-share sales were priced at $162.0394 and $164.6839 per share.
  • The remaining two 500-share sales fetched $166.8195 and $170.4094 per share.
  • Scholl’s indirect beneficial ownership through Bioptima fell to 12,500 American depositary shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-464091), on November 16, 2026, and is solely responsible for the information contained therein.